“sanofi-aventis” Archives

Entry Author Date Location
How Sanofi Could Start Off on the Right Foot in Cambridge 02/07/11 Boston
Genocea Announces New CEO, Pfizer to Add Jobs In MA, Ocular Raises $14M, and More Boston-Area Life Sciences News 02/04/11 Boston
EnerNOC Acquires M2M, H3 Launches With Eisai Funding, Genzyme Talks With Sanofi Advance, & More Boston-Area Deals News 02/02/11 Boston
Genzyme-Sanofi Deal Might Be Close, Report Says 02/01/11 Boston
Genzyme Lets Sanofi Conduct Due Diligence 01/31/11 Boston
Clinical Data Stock Soars on FDA Approval, Amgen Buys BioVex, Stromedix Raises $2M, & More Boston-Area Life Sciences News 01/28/11 Boston
Myriant Gets $60M, BioVex Bought By Amgen, Raindance Wraps Up $37.5M, & More Boston-Area Deals News 01/26/11 Boston
Sanofi Extends Genzyme Offer 01/24/11 Boston
Report: Sanofi To Up Genzyme Bid 01/14/11 Boston
Hygieia Progressing with Software and Device to Guide Insulin Dosages for Diabetics 01/03/11 Detroit Ann Arbor
Top Five Biotech Surprises & Innovations of 2010, and Five Trends to Watch for in 2011 12/30/10 San Francisco
Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010 12/27/10 Boston
Testing Experimental Drugs in Combination – A New Trend 12/22/10 San Diego
EveryScape and Bing Expand Partnership, Raytheon Acquires Applied Signal, Avila Inks Sanofi Deal, & More Boston-Area Deals News 12/22/10 Boston
Sanofi Taps Avila Therapeutics for Covalent Cancer Drugs in Potential $800M Deal 12/20/10 Boston
DARPA Backs Pulmatrix’s Lung Treatment, Adimab Scores More Pharma Partners, Semprus Secures $18M, & More Boston-Area Life Sciences News 12/17/10 Boston
BG Medicine Eyes $70M IPO, Nano-Terra Picks Up $17.2M, Rive Technology Raises $25M, & More Boston-Area Deals News 12/15/10 Boston
Sanofi Extends Deadline for Genzyme Offer 12/13/10 Boston
Watch Out Big Pharma: PATH, WHO Show that Nonprofits Can Develop New Meningitis Vaccine 12/08/10 Seattle
Orexigen Beats the Odds, Wins OK from FDA Panel for Obesity Drug 12/07/10 San Diego
How To Keep Academic/Big Pharma Alliances from Going off the Rails 11/30/10 San Diego
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Genzyme to Let Diagnostics Unit Loose for $265M 11/18/10 Boston
Paul Allen Donates $9M for Edgy Neuroscience, Biotech Projects at MIT, Stanford, UW 11/18/10 Seattle
Roche Dumps RNAi, Sends Shock Waves Through Alnylam, Tekmira 11/17/10 National
Biogen Idec Chief Aims to Make Firm More Like Biotech and Less Like Pharma with Restructuring Plan 11/04/10 Boston
Hyperion Hits Goal in Trial for Rare-Disease Drug, Prepping FDA Application 11/03/10 San Francisco
Arena Obesity Drug Fails to Win FDA Approval, May Need More Clinical Testing 10/25/10 San Diego
Aastrom Maps Out Pivotal Trial Strategy With Adult Stem Cell Therapy 10/22/10 Detroit Ann Arbor
Exelixis Seeks to Climb From the Penalty Box, Prove its Lead Drug Still Has Legs 10/20/10 San Francisco
Page 2 of 6 « previous page · next page »